CN112625292B - Preparation method of degradable shape memory polymer medical splint - Google Patents

Preparation method of degradable shape memory polymer medical splint Download PDF

Info

Publication number
CN112625292B
CN112625292B CN202011494446.6A CN202011494446A CN112625292B CN 112625292 B CN112625292 B CN 112625292B CN 202011494446 A CN202011494446 A CN 202011494446A CN 112625292 B CN112625292 B CN 112625292B
Authority
CN
China
Prior art keywords
caprolactone
butyrolactone
gamma
epsilon
methylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011494446.6A
Other languages
Chinese (zh)
Other versions
CN112625292A (en
Inventor
李志波
沈勇
阚泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Boyuan Polymer Materials Research Institute Co ltd
Original Assignee
Qingdao Boyuan Polymer Materials Research Institute Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Boyuan Polymer Materials Research Institute Co ltd filed Critical Qingdao Boyuan Polymer Materials Research Institute Co ltd
Priority to CN202011494446.6A priority Critical patent/CN112625292B/en
Publication of CN112625292A publication Critical patent/CN112625292A/en
Application granted granted Critical
Publication of CN112625292B publication Critical patent/CN112625292B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
    • C08J7/12—Chemical modification
    • C08J7/123—Treatment by wave energy or particle radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
    • A61F5/01—Orthopaedic devices, e.g. long-term immobilising or pressure directing devices for treating broken or deformed bones such as splints, casts or braces
    • A61F5/04—Devices for stretching or reducing fractured limbs; Devices for distractions; Splints
    • A61F5/05—Devices for stretching or reducing fractured limbs; Devices for distractions; Splints for immobilising
    • A61F5/058—Splints
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/07—Aldehydes; Ketones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/14—Peroxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/16—Nitrogen-containing compounds
    • C08K5/22—Compounds containing nitrogen bound to another nitrogen atom
    • C08K5/23—Azo-compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
    • C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/06—Biodegradable
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2201/00—Properties
    • C08L2201/12—Shape memory

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nursing (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

The invention provides a degradable shape memory polymer medical splint and a preparation method thereof. The medical splint material provided by the invention is prepared by mixing an aliphatic polyester material with a main chain lateral group containing double bond functional groups and a photoinitiator according to a certain proportion, melting, blending, extruding into sheets, molding, perforating and irradiating by ultraviolet. Compared with the polycaprolactone type medical splint used at present, the medical splint provided by the invention has higher strength and deformation recovery rate and smaller retraction force, so that the medical splint has better fixing effect and stronger comfort.

Description

Preparation method of degradable shape memory polymer medical splint
Technical Field
The invention relates to the field of high polymer materials and medical instruments, in particular to a preparation method of a degradable shape memory high polymer medical splint.
Background
The shape memory polymer material is a kind of intelligent material, and refers to a material capable of sensing the stimulus of environmental change (such as temperature, light, electric field, magnetic field, etc.) and responding to the change, so as to adjust the mechanical parameters (such as shape, position, strain, etc.) until the material returns to the initial state. Thermotropic shape memory polymer material is the most common shape memory polymer material in the earliest development. Thermotropic shape memory polymer generally contains two-phase structure, including stationary phase and reversible phase, wherein the stationary phase provides the permanent form of the material, generally composed of cross-linked structure in the polymer; the reversible phase provides a temporary form of the material, and the material can reversibly generate hardening and softening transformation along with temperature change, and the transformation can be glass transition or melting transformation.
In order to avoid secondary injury after fracture or orthopedic surgery, patients need to be externally fixed clinically. Although the plaster splint has low price, the plaster splint has high density, poor air permeability, long curing time, complex operation, no secondary forming and poor X-ray permeability, is not beneficial to observing the postoperative recovery condition of a patient in time and brings inconvenience to treatment. The medical splint material widely used clinically at present is a cross-linked polycaprolactone material with a shape memory function, and can be softened at a lower temperature (55-65 ℃) due to a lower melting point (57 ℃) of polycaprolactone, and can be recrystallized and hardened to form after being cooled. The medical splint has the advantages of simple and convenient operation, is particularly suitable for fixing complicated parts such as the head, the neck and the like, and also has the advantages of repeated use, natural degradation after being discarded and the like. However, there are no reactive groups on the main chain of polycaprolactone, and the crosslinking and curing are usually performed by irradiation with high-energy electron beam or gamma ray, and the crosslinking and curing effect is achieved by generating active free radicals on the main chain of polycaprolactone (CN109608842A, CN 10169874B). On one hand, the high-energy rays can cause the main chain of polycaprolactone to break and degrade while crosslinking the polycaprolactone, so that the mechanical property of the material is reduced, and the fixing effect of the splint is influenced. On the other hand, the crosslinking mode is to randomly generate crosslinking sites on the main chain structure, so that the product performance has poor controllability and the repeatability among batches is poor.
The glass transition temperature of the poly (4-hydroxybutyrate) is-45 ℃, the melting point is 60 ℃, the poly (4-hydroxybutyrate) is similar to that of polycaprolactone, the poly (caprolactone) has good shape memory function after crosslinking, can be softened at a lower temperature (55-65 ℃), and is an ideal material for preparing degradable medical splints. In addition, as the ester bond density in the poly (4-hydroxybutyrate) main chain is higher than that of polycaprolactone, the medical splint theoretically has higher mechanical strength than that of polycaprolactone, and the medical splint obtained after crosslinking has higher strength and better fixing effect. However, poly (4-hydroxybutyrate) also suffers from the lack of reactive groups in the backbone.
In order to solve the problems, the invention provides a preparation method of a degradable shape memory polymer material and application of the degradable shape memory polymer material in the aspect of medical splints. The invention introduces crosslinkable double bond functional groups in the main chain structure of polycaprolactone or poly (4-hydroxybutyrate) through copolymerization, realizes double bond crosslinking through ultraviolet irradiation, obtains a degradable shape memory polymer material, and is used for preparing medical splints. Compared with the methods reported in the prior art, the method provided by the invention has the following advantages: 1) the polymer structure main chain contains reactive double bond functional groups, so that the polymer structure main chain can generate crosslinking reaction under the irradiation of ultraviolet light with lower energy, and the breakage of the main chain structure caused by the irradiation of high-energy rays is avoided; 2) the density of double bond functional groups on the main chain of the polymer can be regulated, so that the subsequent crosslinking density can be conveniently controlled, and the regulation and control on the strength, the deformation recovery rate and the shrinkage force of the material can be realized; 3) by controlling the composition and content of the comonomer in the polymer main chain, the thermal transition temperature of the obtained material can be regulated, and the regulation of material softening and molding can be realized in a larger temperature range (40-60 ℃).
Disclosure of Invention
The invention aims to provide a preparation method of a degradable shape memory polymer medical splint.
A preparation method of a degradable shape memory polymer medical splint comprises the following steps:
(1) uniformly mixing a polyester material with a main chain side group containing double-bond functional groups and a photoinitiator according to a certain proportion, heating the mixture in a double-screw extruder to a molten state, and extruding the mixture to form a sheet;
(2) the obtained sheet is punched according to the requirement, and then ultraviolet irradiation treatment is carried out.
In the preparation method, the chemical structure of the polyester with the main chain side group containing double bond functional groups is shown as the formula (I):
(I)
the method is characterized in that n and m are natural numbers which are more than or equal to 1, x, y and z are natural numbers which are more than or equal to 5, x/(x + y + z) is 0.01-0.2, y/(x + y + z) is 0-0.99, and z/(x + y + z) is 0-0.99.
According to an embodiment of the present invention, the polyester having a pendant backbone group with a double bond functional group has a structure of one of:
(II)(III)
(IV)(V)
(VI)
(VII)
wherein x and y are natural numbers of 5 or more.
In the above production process, the polyester of the formula (II) may be obtained by random copolymerization of α -methylene- γ -butyrolactone and γ -butyrolactone, the polyester of the formula (III) may be obtained by random copolymerization of α -methylene- γ -butyrolactone and ε -caprolactone, the polyester of the formula (IV) may be obtained by random copolymerization of α -methylene- ε -caprolactone and γ -butyrolactone, the polyester of the formula (V) may be obtained by random copolymerization of α -methylene- ε -caprolactone and ε -caprolactone, the polyester of the formula (VI) may be obtained by ternary random copolymerization of α -methylene- γ -butyrolactone, γ -butyrolactone and ε -caprolactone, the polyester of the formula (VII) may be obtained by random copolymerization of α -methylene- ε -caprolactone, the gamma-butyrolactone and the epsilon-caprolactone are subjected to ternary random copolymerization.
In the preparation method, the molecular weight of the polyester is preferably 30-300 kDa; the photoinitiator is at least one of methyl vinyl ketone, benzoin, 2-dimethoxy-2-phenylacetophenone, azobisisobutyronitrile, azobisisoheptonitrile, dibenzoyl peroxide, dicumyl peroxide, di-tert-butyl peroxide, lauroyl peroxide, tert-butyl peroxybenzoate, diisopropyl peroxydicarbonate and dicyclohexyl peroxydicarbonate.
In the preparation method, the weight fraction of the polyester material is 95-99.9 parts, and the weight fraction of the photoinitiator is 0.1-5 parts.
The melt blending temperature is 50-80 ℃, and the melt blending extrusion speed is 30-120 rpm.
The wavelength of the ultraviolet light is 200-400 nm, and the intensity of the ultraviolet light is 10-200W/cm 2 The irradiation time is 0.5-10 h.
Detailed Description
The following embodiments specifically describe the present invention, but the present invention is not limited to these embodiments. The examples, where specific techniques or conditions are not indicated, are to be construed according to the techniques or conditions described in the literature in the art or according to the product specifications. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products commercially available.
Wherein the polyester with the side group of the main chain containing double bond functional group is synthesized by the method reported in references (Macromolecules 2020,53, 3380-28089; Macromolecules 2006,39, 2804-2807).
Example 1
96 parts by weight of a random copolyester (M) of alpha-methylene-gamma-butyrolactone and gamma-butyrolactone n 100kDa, wherein alpha-methylene-gamma-The mol fraction of butyrolactone is 2 mol%), 4 weight parts of methyl vinyl ketone are stirred in a high-speed stirrer for 10min and uniformly mixed, the mixture is added into a double-screw extruder to be melted and extruded at 80 ℃, the rotating speed is 50rpm, a plate with the thickness of 2mm is obtained by extrusion, and the plate is perforated, and the aperture is 2 mm. Irradiating with 254nm ultraviolet lamp for 10min at 30W/cm intensity 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Example 2
98 parts by weight of a random copolyester (M) of alpha-methylene-gamma-butyrolactone and epsilon-caprolactone n 150kDa, wherein the mole fraction of the alpha-methylene-gamma-butyrolactone is 4mol percent), 2 parts by weight of azobisisobutyronitrile are stirred in a high-speed stirrer for 15min and uniformly mixed, the mixture is added into a double-screw extruder to be melted and extruded at 80 ℃ and the rotating speed is 80rpm, a plate with the thickness of 2mm is obtained by extrusion, and the plate is perforated and has the aperture of 2 mm. Irradiating with 365nm ultraviolet lamp for 20min at 40W/cm intensity 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Example 3
99 parts by weight of a random copolyester of alpha-methylene-epsilon-caprolactone and epsilon-caprolactone (M) n The alpha-methylene-epsilon-caprolactone comprises 300kDa, wherein the mole fraction of alpha-methylene-epsilon-caprolactone is 1mol percent), 1 part by weight of di-tert-butyl peroxide is stirred in a high-speed stirrer for 10min and uniformly mixed, added into a double-screw extruder and melt-extruded at 80 ℃ at the rotating speed of 100rpm to obtain a plate with the thickness of 2mm, and the plate is punched with the aperture of 2 mm. Irradiating with 254nm ultraviolet lamp at 100W/cm intensity for 30min 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Example 4
98 parts by weight of a random copolyester (M) of alpha-methylene-epsilon-caprolactone and gamma-butyrolactone n 200kDa, wherein the mole fraction of the alpha-methylene-epsilon-caprolactone is 5mol percent), 2 parts by weight of dibenzoyl peroxide are stirred in a high-speed stirrer for 20min and uniformly mixed, and then the mixture is added into a double-screw extruder to be melted and extruded at 80 ℃, the rotating speed is 100rpm and the extrusion is carried outAnd (5) obtaining a plate with the thickness of 2mm, and punching the plate with the aperture of 2 mm. Irradiating with 365nm ultraviolet lamp for 30min at 150W/cm intensity 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Example 5
97 parts by weight of ternary random copolyester (M) of alpha-methylene-gamma-butyrolactone, gamma-butyrolactone and epsilon-caprolactone n 300kDa, wherein the mole fraction of alpha-methylene-gamma-butyrolactone is 3mol percent, the mole fraction of gamma-butyrolactone is 10mol percent), 3 parts by weight of dicumyl peroxide are stirred in a high-speed stirrer for 15min and uniformly mixed, added into a double-screw extruder and melted and extruded at 80 ℃, the rotating speed is 110rpm, a plate with the thickness of 2mm is obtained by extrusion, and the hole diameter is 2 mm. Irradiating with 254nm ultraviolet lamp at 160W/cm intensity for 30min 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Example 6
98 parts by weight of ternary random copolyester (M) of alpha-methylene-epsilon-caprolactone, gamma-butyrolactone and epsilon-caprolactone n The molecular weight of the alpha-methylene-epsilon-caprolactone is 300kDa, the mol fraction of the alpha-methylene-epsilon-caprolactone is 2mol percent, the mol fraction of the gamma-butyrolactone is 5mol percent, 2 parts of tert-butyl peroxybenzoate is stirred in a high-speed stirrer for 20min and uniformly mixed, the obtained mixture is added into a double-screw extruder to be melted and extruded at 80 ℃, the rotating speed is 110rpm, a plate with the thickness of 2mm is obtained through extrusion, and the plate is punched, and the aperture is 2 mm. Irradiating with 254nm ultraviolet lamp at intensity of 180W/cm for 30min 2 And obtaining the medical splint. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
Comparative example 1
Mixing polycaprolactone (M) n 100kDa) was added to a twin-screw extruder and melt extruded at 80 c, 50rpm, to give a 2mm thick sheet, which was perforated to a 2mm pore size. The medical splint was obtained by electron beam irradiation at a dose of 50 kGy. The modulus of elasticity, the deformation recovery rate and the contraction force are shown in Table 1.
TABLE 1 modulus of elasticity, deformation restoring force and contraction force of medical splint material
Modulus of elasticity (MPa) Percent recovery from deformation (%) Contractile force (N)
Comparative example 1 256±10 90±0.5 56±0.8
Example 1 430±15 98±0.3 33±1.2
Example 2 470±12 97±0.4 34±0.8
Example 3 490±16 99±0.5 28±0.7
Example 4 480±14 98±0.5 32±1.4
Example 5 520±12 99.5±0.5 20±0.8
Example 6 500±16 99±0.3 19±0.7
As can be seen from the above table, compared with the polycaprolactone type medical splint obtained by irradiation crosslinking of high-energy electron beams, the medical splint provided by the invention has the advantages that the elastic modulus and the deformation recovery rate are obviously improved, so that the medical splint has better fixing strength, and the secondary damage caused by bone dislocation due to splint deformation is avoided. In addition, compared with a polycaprolactone type medical splint, the contraction force of the medical splint provided by the invention is obviously reduced, and the comfort of a patient is enhanced.

Claims (5)

1. A preparation method of a degradable shape memory polymer medical splint comprises the following steps:
(1) uniformly mixing polyester with a main chain side group containing double bond functional groups and a photoinitiator according to a certain proportion, heating the mixture in a double-screw extruder to a molten state, and extruding the mixture to form a sheet;
(2) punching the obtained sheet according to requirements, and then carrying out ultraviolet irradiation treatment;
the polyester is at least one of a random copolymer of alpha-methylene-gamma-butyrolactone and gamma-butyrolactone, a random copolymer of alpha-methylene-gamma-butyrolactone and epsilon-caprolactone, a random copolymer of alpha-methylene-epsilon-caprolactone and gamma-butyrolactone, a random copolymer of alpha-methylene-epsilon-caprolactone and epsilon-caprolactone, a ternary random copolymer of alpha-methylene-gamma-butyrolactone, gamma-butyrolactone and epsilon-caprolactone, and a ternary random copolymer of alpha-methylene-epsilon-caprolactone, gamma-butyrolactone and epsilon-caprolactone;
the photoinitiator is at least one of methyl vinyl ketone, benzoin, 2-dimethoxy-2-phenylacetophenone, azobisisobutyronitrile, azobisisoheptonitrile, dibenzoyl peroxide, dicumyl peroxide, di-tert-butyl peroxide, lauroyl peroxide, tert-butyl peroxybenzoate, diisopropyl peroxydicarbonate and dicyclohexyl peroxydicarbonate.
2. The method of claim 1, wherein the weight fraction of the polyester with the pendant main chain group containing double bond functional group is 95 to 99.9 parts, and the weight fraction of the photoinitiator is 0.1 to 5 parts.
3. The method of claim 1, wherein the melt blending temperature is 50 to 80 ℃ and the melt blending extrusion speed is 30 to 120 rpm.
4. The method of claim 1, wherein the ultraviolet light has a wavelength of 200-400 nm and an intensity of 10-200W/cm 2 The irradiation time is 0.5-10 h.
5. A medical splint produced by the method according to any one of claims 1 to 4.
CN202011494446.6A 2020-12-17 2020-12-17 Preparation method of degradable shape memory polymer medical splint Active CN112625292B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011494446.6A CN112625292B (en) 2020-12-17 2020-12-17 Preparation method of degradable shape memory polymer medical splint

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011494446.6A CN112625292B (en) 2020-12-17 2020-12-17 Preparation method of degradable shape memory polymer medical splint

Publications (2)

Publication Number Publication Date
CN112625292A CN112625292A (en) 2021-04-09
CN112625292B true CN112625292B (en) 2022-08-23

Family

ID=75316680

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011494446.6A Active CN112625292B (en) 2020-12-17 2020-12-17 Preparation method of degradable shape memory polymer medical splint

Country Status (1)

Country Link
CN (1) CN112625292B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115850667A (en) * 2022-11-01 2023-03-28 青岛科技大学 Preparation method of photo-crosslinked degradable aliphatic polyester elastomer
CN116285269B (en) * 2023-04-04 2023-10-31 江苏尚美医疗器械有限公司 Polycaprolactone thermoplastic plate and preparation method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100555102B1 (en) * 2004-08-27 2006-02-24 한양대학교 산학협력단 Degradable shape memory polyester ionomer resin and its manufacturing method
CN100540604C (en) * 2007-06-01 2009-09-16 哈尔滨工程大学 Alternating magnetic field driven shape memory biodegradable polymer and preparation method
KR100961466B1 (en) * 2008-01-29 2010-06-08 (주) 태웅메디칼 Stent for Chronic Obstructive Pulmonary Disease
US8859691B2 (en) * 2010-01-09 2014-10-14 Klarity Medical & Equipment (Gz) Co., Ltd. Low temperature thermoplastic material and preparing method thereof
PL230303B1 (en) * 2012-04-02 2018-10-31 Centrum Mat Polimerowych I Weglowych Polskiej Akademii Nauk Method for producing bioresorbable and biocompatible thermoplastic elastomers exhibiting shape memory for biomedical applications
CN103709691B (en) * 2012-10-09 2016-11-23 上海微创医疗器械（集团）有限公司 Biodegradable crosslinking polymer and preparation method thereof
WO2014071267A1 (en) * 2012-11-02 2014-05-08 Syracuse University Reversible shape memory polymers exhibiting ambient actuation triggering
CN104387538B (en) * 2014-11-20 2017-03-08 天津大学 There is high-strength shape memory hydrogel of anti tear and preparation method thereof
CN106110398B (en) * 2016-07-06 2019-04-16 西南交通大学 Preparation method with the degradable shape memory high molecule intravascular stent of surface micro-structure
CN106913914A (en) * 2017-04-04 2017-07-04 西南交通大学 A kind of preparation method for visualizing shape memory high molecule intravascular stent
CN109608842B (en) * 2018-12-18 2022-01-14 威高集团有限公司 Low-temperature thermoplastic sheet and preparation method thereof
CN110194834B (en) * 2019-05-07 2020-07-10 西南交通大学 A kind of visible photoinduced shape memory polymer and preparation method thereof
CN111269373B (en) * 2020-02-12 2022-01-04 浙江大学衢州研究院 Preparation method of remodelable shape memory elastomer based on co-crystal

Also Published As

Publication number Publication date
CN112625292A (en) 2021-04-09

Similar Documents

Publication Publication Date Title
Yu et al. Study on the biodegradability of modified starch/polylactic acid (PLA) composite materials
CN112625292B (en) Preparation method of degradable shape memory polymer medical splint
CN105038165B (en) Biological base thermoplastic elastomer with shape memory function and preparation method thereof
WO1992004413A1 (en) Packaging thermoplastics from lactic acid
CN104004143A (en) Photoactive polylactic acid acrylate degradation material
CN111205603B (en) Biodegradable mulch film and preparation method thereof
CN110051888A (en) One kind absorbable compound interface screw sheath flexible and preparation method thereof
WO2005040255A1 (en) Biodegradable material and process for producing the same
CN113563569A (en) Biodegradable polyester material with low melting point and preparation method and application thereof
EP2208759B1 (en) Process for production of molded polylactic acid resin article, compound comprising a crystallization-inducing master batch for use in the process, and molded polylactic acid resin article
CN112175365A (en) A kind of modified eucommia gum/polylactic acid thermoplastic elastomer with shape memory effect and preparation method thereof
CN115057997A (en) Preparation method and application of polylactic acid for producing extinction biaxially oriented film
CN102585461A (en) Method for preparing heat-resisting polylactic acid nanocomposite through irradiation modification
CN110041466A (en) A kind of high fondant-strength poly-lactic acid material and preparation method thereof
CN101735409A (en) Modified polylactic acid material under low irradiation dose and preparation method thereof
CN112625412A (en) Preparation method of poly (4-hydroxybutyrate) low-temperature thermoplastic medical splint
CN109535470B (en) High-efficiency preparation method of high-strength high-toughness degradable polyester polymer
CN116875008A (en) Full-biodegradable material for melt spinning and preparation method thereof
CN113429762A (en) Starch/polylactic acid/PBAT nano composite material and preparation method thereof
CN112608586B (en) Degradable shape memory medical splint and preparation method thereof
CN111558092A (en) Preparation of a bio-based degradable stent medical membrane
JP2003313214A (en) Method for producing crosslinked biodegradable material
CN116003971A (en) High-strength high-toughness biodegradable plastic and preparation method thereof
JP5126670B2 (en) Method for producing heat-resistant biodegradable polyester
CN112972762A (en) Degradable resin and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant